(Q33904326)

English

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

0 references

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Calvet X

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

García N

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

López T

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gisbert JP

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gené E

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Roque M

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

603-609

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Canadian Helicobacter pylori consensus conference. Canadian Association of Gastroenterology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Effect of transforming growth factor alpha and interleukin 8 on somatostatin release from canine fundic D cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Mast cells mediate acid-induced augmentation of opossum esophageal blood flow via histamine and nitric oxide

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Comparison of one or two weeks of lansoprazole, amoxicillin, and clarithromycin in the treatment of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Low dose of clarithromycin in triple therapy for the eradication of Helicobacter pylori: one or two weeks?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Treatment of Helicobacter pylori Infection: A Review of the World Literature

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Antibiotic resistance in Helicobacter pylori: implications for therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Two-week dual vs. one-week triple therapy for cure of Helicobacter pylori infection in primary care: a multicentre, randomized trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Geographic distribution of vacA allelic types of Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00744.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2000.00744.X

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33904326&oldid=1586429940"